Michael Mark
50Patents
23h-index
43Co-inventors
88Inventor score
Filing activity: Mar 23, 1989 → May 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7407955B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 120 | Expired |
| US8232281B2 | Uses of DPP-IV inhibitors | Human Necessities | 105 | Active |
| US8119648B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 97 | Active |
| US8178541B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 96 | Active |
| US7109192B2 | Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 93 | Expired |
| US7482337B2 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Human Necessities | 79 | Expired |
| US6617325B1 | Biphenyl derivatives, production thereof and uses as medicines | Human Necessities | 67 | Expired |
| US7495005B2 | Xanthine derivatives, their preparation and their use in pharmaceutical compositions | Chemistry; Metallurgy | 63 | Expired |
| US7569574B2 | Purine derivatives, the preparation thereof and their use as pharmaceutical compositions | Human Necessities | 63 | Expired |
| US7560450B2 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 63 | Expired |
| US7566707B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 63 | Expired |
| US8673927B2 | Uses of DPP-IV inhibitors | Human Necessities | 62 | Active |
| US7838529B2 | Xanthine derivates, their preparation and their use in pharmaceutical compositions | Chemistry; Metallurgy | 52 | Active |
| US9034883B2 | Vasoprotective and cardioprotective antidiabetic therapy | Chemistry; Metallurgy | 51 | Active |
| US9186392B2 | Combination therapy | Human Necessities | 45 | Active |
| US8664232B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 43 | Active |
| US9149478B2 | Diabetes therapy | Human Necessities | 36 | Active |
| US8513264B2 | Combination therapy for the treatment of diabetes and related conditions | Human Necessities | 35 | Active |
| US8551957B2 | Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate | Human Necessities | 32 | Active |
| US9457029B2 | Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin | Human Necessities | 27 | Active |
| US9321791B2 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | Chemistry; Metallurgy | 27 | Active |
| US9173859B2 | Uses of DPP IV inhibitors | Human Necessities | 26 | Active |
| US5455273A | N,N-disubstituted arylcycloalkylamines, the salts thereof, pharmaceutical compositions containing these compounds and the use thereof and processes for preparing them | Chemistry; Metallurgy | 24 | Expired |
| US7696212B2 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Human Necessities | 11 | Active |
| US10406172B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 11 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.